Skip to content

Eikon Therapeutics, Inc. EIKN Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

MYR Group logo
MYR GroupMYRG
$50.36M+18.9%
Huntsman logo
HuntsmanHUN
$403M+5.8%
Nuvation Bio logo
Nuvation BioNUVB
$3.6M-32.5%
Progyny logo
ProgynyPGNY
$24.28M-9.9%
Cimpress plc logo
Cimpress plcCMPR
$106.88M+37.8%
HTF
Heartflow, Inc. Common StockHTFL
$14.41M

Other financials

Income statement

See full
Operating income-$87.3M-22.3%
Net income-$83.0M-21.6%
EPS (diluted)-$2.46+90.9%

Balance sheet

See full
Cash & equivalents$161.2M-21.2%
Total debt$254.8M
Total equity$550.7M+186%
Total assets$850.8M

Cash flow

See full
Operating cash flow-$89.8M-64.7%
CapEx$262.0K-98.8%
Free cash flow-$90.1M-17.1%

Valuation

See full
Market cap$521.35M

Where this comes from

Reported directly by Eikon Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Eikon Therapeutics, Inc. ’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eikon Therapeutics, Inc. 's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Eikon Therapeutics, Inc. 's operating lease ROU assets?
Eikon Therapeutics, Inc. (EIKN) reported operating lease ROU assets of $91.07M in Q1 2026.
What does operating lease ROU assets mean?
This asset represents the company's right to use a leased item, such as office space or data center facilities, over the lease term. It is recognized under modern accounting standards to reflect the financial commitment of long-term operating leases. It provides visibility into the company's fixed operational footprint.